|
Name |
(7R,10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14,23-tetrone
|
Molecular Formula | C28H37N3O7 | |
IUPAC Name* |
(7R,10R,11R,12Z,17Z,19Z,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14,23-tetrone
|
|
SMILES |
C[C@@H]1/C=C\C(=O)NC/C=C\C(=C/[C@H](CC(=O)CC2=NC(=CO2)C(=O)N3CCC[C@@H]3C(=O)O[C@@H]1C(C)C)O)\C
|
|
InChI |
InChI=1S/C28H37N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5,7,9-10,13,16-17,19-20,23,26,32H,6,8,11-12,14-15H2,1-4H3,(H,29,34)/b7-5-,10-9-,18-13-/t19-,20-,23-,26-/m1/s1
|
|
InChIKey |
JOOMGSFOCRDAHL-KJHAIBPLSA-N
|
|
Synonyms |
(7R,10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14,23-tetrone; 21102-49-8; Virginiamycin M2; (7R,10R,11R,12Z,17Z,19Z,21S)-21-Hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14,23-tetrone
|
|
CAS | 21102-49-8 | |
PubChem CID | 21944116 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 527.6 | ALogp: | 2.4 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 139.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 38 | QED Weighted: | 0.531 |
Caco-2 Permeability: | -4.771 | MDCK Permeability: | 0.00000934 |
Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.586 |
Human Intestinal Absorption (HIA): | 0.526 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.98 |
Blood-Brain-Barrier Penetration (BBB): | 0.57 | Plasma Protein Binding (PPB): | 73.40% |
Volume Distribution (VD): | 0.823 | Fu: | 24.04% |
CYP1A2-inhibitor: | 0.017 | CYP1A2-substrate: | 0.074 |
CYP2C19-inhibitor: | 0.039 | CYP2C19-substrate: | 0.072 |
CYP2C9-inhibitor: | 0.116 | CYP2C9-substrate: | 0.015 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.054 |
CYP3A4-inhibitor: | 0.586 | CYP3A4-substrate: | 0.275 |
Clearance (CL): | 8.611 | Half-life (T1/2): | 0.888 |
hERG Blockers: | 0.026 | Human Hepatotoxicity (H-HT): | 0.872 |
Drug-inuced Liver Injury (DILI): | 0.942 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.097 | Maximum Recommended Daily Dose: | 0.93 |
Skin Sensitization: | 0.376 | Carcinogencity: | 0.901 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.533 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003558 | 0.750 | D05AFC | 0.686 | ||||
ENC005288 | 0.641 | D05MNW | 0.360 | ||||
ENC005287 | 0.612 | D07XGH | 0.360 | ||||
ENC005087 | 0.272 | D03LJR | 0.270 | ||||
ENC003855 | 0.256 | D0V7WS | 0.261 | ||||
ENC003645 | 0.254 | D0K3QS | 0.260 | ||||
ENC001855 | 0.253 | D08NLN | 0.253 | ||||
ENC005850 | 0.252 | D06YFA | 0.251 | ||||
ENC002483 | 0.249 | D0ES1Q | 0.247 | ||||
ENC002520 | 0.248 | D0Z4UN | 0.242 |